Amgen Wins Another Key Approval for This Potential Blockbuster Cancer Drug

Amgen Wins Another Key Approval for This Potential Blockbuster Cancer Drug

Earlier this month, the European Commission gave Lumykras the go-ahead as a treatment for lung cancer.